Literature DB >> 1211307

An anti-inflammatory substance in normal human plasma.

M J Smith, A W Ford-Hutchinson.   

Abstract

A substance of low molecular weight, below 1000 daltons, has been separated from normal human plasma by a stepwise process involving ultrafiltration followed by column chromatography. The spectrum of anti-inflammatory activity of the active fraction in a variety of animal models shows that it is most active in situations in which the emigration of circulating leucocytes plays the more prominent role. The fraction exerts a selective action on the release of chemotactic factors after the activation in vitro of the complement cascade by the alternate but not by the classical pathway. The existence of the plasma fraction raises several interesting queries. Is it part of the naturally occurring control mechanisms in inflammation? What is its relevance to human disease, e.g., rheumatoid arthritis, and do conventional antirheumatic drugs interact with it? Does its lack of activity against chemical mediators of inflammation and their generating systems throw any light on the importance of these materials in inflammatory reactions?

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1211307     DOI: 10.1007/bf02205238

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  19 in total

1.  Mode of action of an anti-inflammatory fraction from normal human plasma.

Authors:  J R Walker; M J Smith; A W Ford-Hutchinson; F J Billimoria
Journal:  Nature       Date:  1975-04-03       Impact factor: 49.962

Review 2.  Neutrophil proteases in inflammation.

Authors:  A Janoff
Journal:  Annu Rev Med       Date:  1972       Impact factor: 13.739

3.  Anti-inflammatory and irritant effects of a fraction from normal human plasma.

Authors:  P N Elliott; A W Ford-Hutchinson; M J Smith
Journal:  Br J Pharmacol       Date:  1974-02       Impact factor: 8.739

Review 4.  The inflammatory mediators.

Authors:  P A Ward
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

5.  Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes.

Authors:  I M Goldstein; G Weissmann
Journal:  J Immunol       Date:  1974-11       Impact factor: 5.422

6.  Anti-inflammatory activity in human plasma.

Authors:  A W Ford-Hutchinson; M Y Insley; P N Elliott; E A Sturgess; M J Smith
Journal:  J Pharm Pharmacol       Date:  1973-11       Impact factor: 3.765

7.  The effects of a human plasma fraction on carrageenan-induced paw oedema in the rat.

Authors:  A W Ford-Hutchinson; P N Elliott; J P Bolam; M J Smith
Journal:  J Pharm Pharmacol       Date:  1974-11       Impact factor: 3.765

8.  Effects of a human plasma fraction on skin reactions in the rat and rabbit.

Authors:  J P Bolam; A W Ford-Hutchinson; P N Elliott; M J Smith
Journal:  J Pharm Pharmacol       Date:  1974-08       Impact factor: 3.765

9.  A human plasma fraction with anti-inflammatory but without either analgesic or antipyretic properties.

Authors:  M J Smith; A J Colledge; P N Elliott; J P Bolam; A W Ford-Hutchinson
Journal:  J Pharm Pharmacol       Date:  1974-10       Impact factor: 3.765

10.  Mode of action of antirheumatic drugs.

Authors:  J N McArthur; P D Dawkins; M J Smith; E B Hamilton
Journal:  Br Med J       Date:  1971-06-19
View more
  3 in total

1.  Platelets, prostaglandins and inflammation.

Authors:  M J Smith; J R Walker; A W Ford-Hutchinson; D G Penington
Journal:  Agents Actions       Date:  1976-11

2.  Anti-inflammatory drugs, prostaglandins and leucocyte migration.

Authors:  J R Walker; M J Smith; A W Ford-Hutchinson
Journal:  Agents Actions       Date:  1976-09

3.  Purification and characterization of an anti-inflammatory factor (AIF) from bovine serum.

Authors:  E Misaka; K Matsuda; K Kobayashi; Y Endo; T Kojima; Y Iizuka
Journal:  Agents Actions       Date:  1978-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.